In this episode, Jason Stone sits down with Thomas Reed, a prostate cancer survivor, advocate, and leader of TEXUS2 in Houston, Texas. Diagnosed in 2008 with a Gleason 3+4, Thomas chose a path of proton radiation and short-term hormone therapy at MD Anderson. Sixteen years later, he’s cancer-free, active in his community, and dedicated to supporting other men through awareness and early detection.Thomas shares: • Why he chose proton therapy over surgery • The long-term side effects and how he managed them • The role of early PSA testing in saving his life • The importance of breaking stigma in men’s health, especially in communities of color • His journey into advocacy and leadership at TEXUS2His Support Group: www.TexUsToo.orgWhether you’re newly diagnosed, supporting a loved one, or learning about treatment options, this conversation offers encouragement, blunt truths, and practical advice from someone who’s been through it all.Disclaimer: The content provided on 'Prostate Cancer: The Road to Recovery' is for informational and educational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of qualified healthcare providers with any questions you may have regarding a medical condition. Reliance on any information provided on this channel is solely at your own risk.

In this conversation, Jason Stone and Richard Gao discuss Richard's journey with prostate cancer, including his diagnosis, treatment options, and the emotional and physical challenges he faced. They explore the importance of research, lifestyle changes, and mental health in coping with cancer. The discussion also touches on the role of AI in healthcare, the differences in healthcare systems, and the significance of community support. Richard shares his insights on diet, exercise, and the future of cancer treatments, emphasizing the need for patient empowerment and informed decision-making.

In this powerful conversation, Jason Stone speaks with Dwayne Alleyne, a nurse, educator, and recent prostate cancer patient, about his unexpected diagnosis, the role of genetic risk (BRCA2), and the challenges of deciding between surgery and radiation. Dwayne shares how opening up to his church community and online groups brought unexpected support, and why vulnerability is critical for men’s health. They discuss PSA screening pitfalls, family history, and the importance of second opinions and advanced imaging. This episode offers valuable insights for men at risk, survivors, and anyone supporting a loved one with prostate cancer.

Subscribe to our newletter for the "Beyond the Mic" topics:▶ https://prostate-cancer-the-road-to-recovery.kit.com/57d8235013SummaryIn this conversation, I share insights from the Zero Prostate Cancer Support Group Leader Conference, discussing advancements in imaging techniques, the role of biopsies, radio ligand therapy, biomarker testing, and the importance of communication among medical teams. I emphasize the significance of patient advocacy, the impact of AI in treatment decisions, and the need for community support for those diagnosed with prostate cancer.I was diagnosed with aggressive metastasized prostate cancer at 52 years old. On this podcast, we talk about it. #metastasized #prostate #cancer

SummaryIn this conversation, Jason Stone interviews Kenny Spaulding, a prostate cancer survivor, who shares his journey from diagnosis to treatment and recovery. Kenny discusses the importance of community support, the emotional challenges of facing cancer, and the lessons learned throughout his experience. He emphasizes the need for men to seek medical help early and to not shy away from vulnerability. Kenny also highlights the positive changes in his life and mindset since his diagnosis, encouraging others to fight against cancer with hope and determination.▶ https://www.youtube.com/@Rockerkenny88I was diagnosed with aggressive metastasized prostate cancer at 52 years old. On this podcast, we talk about it. #metastasized #prostate #cancer

Unlock the power of your own body against cancer. This episode explores immunotherapy for advanced prostate cancer, featuring Provenge (sipuleucel-T), a groundbreaking personalized vaccine that teaches your immune system to fight. Learn how this innovative approach is transforming treatment for metastatic castration-resistant prostate cancer (mCRPC), navigating challenges like the 'cold' tumor environment, and opening new frontiers for personalized care

This episode dives deep into how we treat advanced prostate cancer by targeting testosterone, specifically comparing surgical removal of the testicles (orchiectomy) with medical hormone therapy. You'll discover how these approaches stack up in terms of effectiveness for different patients, especially those with more challenging prognoses. We also explore the wide range of side effects patients face when testosterone levels drop, from impacts on sexual function and bone health to everyday challenges like fatigue and mood changes. Plus, we talk about the latest ways doctors and patients are managing these side effects to improve quality of life. It's a comprehensive look at how these crucial treatments affect a man's body and life.

Chris Hartley from RiseWithHart joins me for a raw, honest conversation about cancer, burnout, healing, and what it means to truly rise. No filters. Just truth.

In this episode, we delve into the powerful role diet plays in supporting prostate cancer health. It's crucial to understand that there is NO single diet or list of foods that will "cure" cancer. Instead, the approach, similar to integrative treatment, is to integrate many helpful foods into your diet. We break down five evidence-backed dietary changes that are strongly supported by research to support prostate cancer health and potentially be "cure supportive.”

Explore PROTACs, the new frontier in prostate cancer treatment that destroys cancer-feeding proteins, with one drug currently in Phase 3 clinical trials. Learn why annual PSA tests are crucial for early detection in men aged 40-70 and understand NCCN guidelines for screening older men, considering factors like life expectancy. Gain insights into personalized treatment options and the importance of informed decisions for managing prostate cancer.